BlackRock Fund Advisors - CELLULAR BIOMEDICINE GROUP I ownership

CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 34 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of CELLULAR BIOMEDICINE GROUP I
ValueSharesWeighting
Q4 2016$5,124,000
+4.9%
391,135
+16.1%
0.00%0.0%
Q3 2016$4,883,000
+29.7%
336,772
+7.3%
0.00%0.0%
Q2 2016$3,765,000
-20.5%
313,978
+23.6%
0.00%0.0%
Q1 2016$4,738,000
-15.8%
254,026
-2.9%
0.00%0.0%
Q4 2015$5,624,000
+30.2%
261,716
+2.6%
0.00%0.0%
Q3 2015$4,320,000
-55.3%
255,165
-1.1%
0.00%
-50.0%
Q2 2015$9,673,000257,8760.00%
Other shareholders
CELLULAR BIOMEDICINE GROUP I shareholders Q4 2015
NameSharesValueWeighting ↓
PLATINUM INVESTMENT MANAGEMENT LTD 672,885$11,123,0000.26%
AWM Investment Company, Inc. 80,165$1,325,0000.25%
Nikko Asset Management Americas, Inc. 532,318$8,799,0000.17%
ARK Investment Management 314,378$5,197,0000.13%
Sumitomo Mitsui Trust Holdings, Inc. 528,418$8,735,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 32,100$531,0000.01%
Mizuho Securities Co. Ltd. 300$5,0000.01%
GEODE CAPITAL MANAGEMENT, LLC 148,815$2,459,0000.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 18,629$308,0000.00%
STATE OF WISCONSIN INVESTMENT BOARD 16,100$237,0000.00%
View complete list of CELLULAR BIOMEDICINE GROUP I shareholders